Selected article for: "ace substrate and active site"

Author: Guy, J.L.; Lambert, D.W.; Warner, F.J.; Hooper, N.M.; Turner, A.J.
Title: Membrane-associated zinc peptidase families: comparing ACE and ACE2
  • Cord-id: 7ibc0yvr
  • Document date: 2005_8_1
  • ID: 7ibc0yvr
    Snippet: In contrast to the relatively ubiquitous angiotensin-converting enzyme (ACE), expression of the mammalian ACE homologue, ACE2, was initially described in the heart, kidney and testis. ACE2 is a type I integral membrane protein with its active site domain exposed to the extracellular surface of endothelial cells and the renal tubular epithelium. Here ACE2 is poised to metabolise circulating peptides which may include angiotensin II, a potent vasoconstrictor and the product of angiotensin I cleava
    Document: In contrast to the relatively ubiquitous angiotensin-converting enzyme (ACE), expression of the mammalian ACE homologue, ACE2, was initially described in the heart, kidney and testis. ACE2 is a type I integral membrane protein with its active site domain exposed to the extracellular surface of endothelial cells and the renal tubular epithelium. Here ACE2 is poised to metabolise circulating peptides which may include angiotensin II, a potent vasoconstrictor and the product of angiotensin I cleavage by ACE. To this end, ACE2 may counterbalance the effects of ACE within the renin–angiotensin system (RAS). Indeed, ACE2 has been implicated in the regulation of heart and renal function where it is proposed to control the levels of angiotensin II relative to its hypotensive metabolite, angiotensin-(1–7). The recent solution of the structure of ACE2, and ACE, has provided new insight into the substrate and inhibitor profiles of these two key regulators of the RAS. As the complexity of this crucial pathway is unravelled, there is a growing interest in the therapeutic potential of agents that modulate the activity of ACE2.

    Search related documents:
    Co phrase search for related documents
    • ace active site and acute respiratory syndrome: 1
    • ace activity and active site: 1, 2, 3, 4
    • ace activity and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • ace biology and acute respiratory syndrome: 1, 2
    • ace different and active site: 1
    • ace different and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • ace effect and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • ace human homologue and acute respiratory syndrome: 1, 2
    • ace inhibition and active site: 1
    • ace inhibition and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • ace inhibitor and active site: 1
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor substrate and acute respiratory syndrome: 1
    • ace inhibitor treatment and acute respiratory syndrome: 1, 2, 3, 4
    • ace substrate and active site: 1, 2
    • ace substrate and acute respiratory syndrome: 1, 2, 3, 4
    • ace substrate specificity and acute respiratory syndrome: 1, 2
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site model and acute respiratory syndrome: 1, 2